SAVE UP TO $700 IF YOU BOOK BEFORE JULY 17 2021
- 00DAYS
- 00HRS
- 00MINS
- 00SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San DiegoMaria Jure-Kunkel, Ph.D.Head of Late Stage Oncology Translational Medicine at Genmab
Profile
Maria Jure-Kunkel is currently the Head of Late Stage Translational Research at Genmab. Prior to that, she led Translational Medicine and Discovery/Translational Research teams at MedImmune/AstraZeneca and at Bristol-Myers Squibb. In her 20+ years of pharmaceutical experience, Maria has been the recipient of several patents in the field of Immuno-Oncology and had the privilege to contribute to the development of several IO agents including urelumab, ipilimumab and nivolumab.
Agenda Sessions
DuoBody®-PD-L1x4-1BB [GEN1046]: Next Generation Checkpoint Immunotherapy Combining PD-1/PD-L1 Blockade with Conditional 4-1BB T-cell Activation
On DemandView SessionTransforming Therapeutic Targets
10:15amView Session